2191-219x

EJNMMI Research

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 854 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact854 DOIs
2

Attach ORCID iDs across 657 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact657 DOIs
3

Add license metadata to 197 records

License metadata tells indexers and readers how each article may be reused.

Low impact197 DOIs

DOIs for this ISSN

Showing the top 5 of 1642 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Kinetic analysis and test-retest variability of the radiolig… (10.1186/2191-219x-2-15)
Abstract References ORCID License
183.88 68
2 In vivo TSPO imaging in patients with multiple sclerosis: a… (10.1186/2191-219x-3-30)
Abstract References ORCID License
179.24 61
3 Gastrointestinal transit measurements in mice with 99mTc-DTP… (10.1186/2191-219x-3-60)
Abstract ORCID License
168.04 173
4 Lower striatal dopamine D2/3 receptor availability in obese… (10.1186/2191-219x-1-37)
Abstract ORCID License
162.77 147
5 Anaesthesia and physiological monitoring during in vivo imag… (10.1186/2191-219x-2-44)
Abstract ORCID License
159.53 133
6 Emerging role of radiolabeled nanoparticles as an effective… (10.1186/2191-219x-2-39)
Abstract ORCID License
158.29 128
7 Post-radioembolization yttrium-90 PET/CT - part 2: dose-resp… (10.1186/2191-219x-3-57)
Abstract ORCID License
157.53 125
8 Radiofluorination using aluminum-fluoride (Al18F) (10.1186/2191-219x-3-36)
Abstract ORCID License
152.20 106
9 The PET-derived tumor-to-blood standard uptake ratio (SUR) i… (10.1186/2191-219x-3-77)
Abstract ORCID License
152.20 106
10 Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-pe… (10.1186/2191-219x-2-28)
Abstract ORCID License
151.59 104
11 Quantification of 99mTc-DPD concentration in the lumbar spin… (10.1186/2191-219x-3-45)
Abstract ORCID License
149.67 98
12 18F-fluoride PET: changes in uptake as a method to assess re… (10.1186/2191-219x-1-4)
Abstract ORCID License
148.33 94
13 Optimized dose regimen for whole-body FDG-PET imaging (10.1186/2191-219x-3-63)
Abstract ORCID License
143.93 82
14 PET imaging of brain inflammation during early epileptogenes… (10.1186/2191-219x-2-60)
Abstract ORCID License
142.73 79
15 Post-radioembolization yttrium-90 PET/CT - part 1: diagnosti… (10.1186/2191-219x-3-56)
Abstract ORCID License
142.32 78
16 Reproducibility of quantitative (R)-[11C]verapamil studies (10.1186/2191-219x-2-1)
Abstract References ORCID License
141.50 25
17 Suitability of bilateral filtering for edge-preserving noise… (10.1186/2191-219x-1-23)
Abstract ORCID License
134.95 62
18 Blood–brain barrier P-glycoprotein function in healthy subje… (10.1186/2191-219x-2-57)
Abstract ORCID License
134.95 62
19 Assessment of acquisition protocols for routine imaging of Y… (10.1186/2191-219x-3-11)
Abstract ORCID License
134.43 61
20 Enhanced diagnostic accuracy for quantitative bone scan usin… (10.1186/2191-219x-3-83)
Abstract ORCID License
133.90 60
21 Estimation of absorbed dose to the kidneys in patients after… (10.1186/2191-219x-2-49)
Abstract ORCID License
132.81 58
22 Quantitative capabilities of four state-of-the-art SPECT-CT… (10.1186/2191-219x-2-45)
Abstract ORCID License
132.26 57
23 Comparison of cyclic RGD peptides for αvβ3 integrin detectio… (10.1186/2191-219x-3-38)
Abstract ORCID License
131.11 55
24 Imaging technologies for preclinical models of bone and join… (10.1186/2191-219x-1-11)
Abstract ORCID License
129.32 52
25 Experimental α-particle radioimmunotherapy of breast cancer… (10.1186/2191-219x-1-18)
Abstract ORCID License
126.76 48
26 Correction of scan time dependence of standard uptake values… (10.1186/2191-219x-4-18)
Abstract ORCID License
126.09 47
27 SUVref: reducing reconstruction-dependent variation in PET S… (10.1186/2191-219x-1-16)
Abstract ORCID License
124.71 45
28 Bone Scan Index: a prognostic imaging biomarker for high-ris… (10.1186/2191-219x-3-9)
Abstract ORCID License
123.99 44
29 Design and preclinical evaluation of a 99mTc-labelled diabod… (10.1186/2191-219x-4-13)
Abstract ORCID License
123.99 44
30 Improved labelling of DTPA- and DOTA-conjugated peptides and… (10.1186/2191-219x-2-4)
Abstract ORCID License
123.26 43
31 Multivariate analysis of brain metabolism reveals chemothera… (10.1186/2191-219x-3-22)
Abstract References ORCID License
123.04 16
32 A method for model-free partial volume correction in oncolog… (10.1186/2191-219x-2-16)
Abstract ORCID License
121.74 41
33 Monitoring tumour response during chemo-radiotherapy: a para… (10.1186/2191-219x-4-12)
Abstract References ORCID License
120.41 15
34 Influence of dietary state and insulin on myocardial, skelet… (10.1186/2191-219x-1-8)
Abstract ORCID License
119.33 38
35 Progression of bone metastases in patients with prostate can… (10.1186/2191-219x-3-64)
Abstract ORCID License
119.33 38
36 Decreased defluorination using the novel beta-cell imaging a… (10.1186/2191-219x-1-33)
Abstract ORCID License
118.48 37
37 Cortical florbetapir-PET amyloid load in prodromal Alzheimer… (10.1186/2191-219x-3-43)
Abstract ORCID License
118.48 37
38 About inflammation and infection (10.1186/2191-219x-3-8)
Abstract ORCID License
117.62 36
39 Comparison of machine learning methods for classifying media… (10.1186/s13550-017-0260-9)
Abstract ORCID
117.12 219
40 Early side effects and first results of radioligand therapy… (10.1186/s13550-015-0114-2)
Abstract ORCID
116.11 209
41 High bone turnover assessed by 18F-fluoride PET/CT in the sp… (10.1186/2191-219x-2-38)
Abstract ORCID License
114.86 33
42 Dual-modality imaging with 99mTc and fluorescent indocyanine… (10.1186/2191-219x-3-33)
Abstract ORCID License
114.86 33
43 Failure of annexin-based apoptosis imaging in the assessment… (10.1186/2191-219x-1-26)
Abstract ORCID License
113.89 32
44 [11C]phenytoin revisited: synthesis by [11C]CO carbonylation… (10.1186/2191-219x-2-36)
Abstract ORCID License
113.89 32
45 A computational pipeline for quantification of pulmonary inf… (10.1186/2191-219x-3-55)
Abstract ORCID License
112.89 31
46 Bone-seeking TRAP conjugates: surprising observations and th… (10.1186/2191-219x-2-13)
Abstract ORCID License
111.85 30
47 Transcriptional response of BALB/c mouse thyroids following… (10.1186/2191-219x-2-32)
Abstract ORCID License
111.85 30
48 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PS… (10.1186/s13550-017-0257-4)
Abstract ORCID
111.52 169
49 Intraoperative 3-D mapping of parathyroid adenoma using free… (10.1186/2191-219x-2-51)
Abstract ORCID License
110.78 29
50 PET radioligand binding to translocator protein (TSPO) is in… (10.1186/s13550-018-0401-9)
Abstract ORCID
110.21 159